Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
U do realize it’s a voluntary program, they weren’t “Chosen” by the fda for it. Apparently someone at vicarious is good at paperwork and can fill out a form or two. I don’t even think vicarious knows what path they will need (most likely de novo). What this breakthrough designation means is that vicarious CAN JUST NOW START TALKING AND WORKING W FDA to determine what regulatory path they should take. (Titan is way past this stage).
The Breakthrough Device designation basically allows companies to benefit from additional FDA input as they work to validate the safety and efficacy of their devices during premarket prototype phase.
A company getting a fda breakthrough designation is basically like a college student going up to a teacher and saying “im really going to suck in this class bc it’s way above my head but tell me what I need to do to get a C in your class by end of the semester”.
This is valued at $1.1B w a prototype.
Yes, which speaks to the importance of camera and visualization. They obvious think JNJs robot could use the help. Titan has 2 camera systems. As stated in the article, Google believes the surgical robots camera is a $3B oppty
Hopefully Medtronic will understand what is at stake and a very interesting development:
https://www.google.com/amp/s/online--news.com/2021/05/27/alphabets-verily-is-pursuing-surgical-robotics-with-renewed-intensity-and-is-in-talks-with-johnson-johnson-for-a-lucrative-new-deal-goog/amp/
Shorts are toast - bunch of helens
The offerings
He got here in 2017
Yes Pink Floyd said this board was useless and clueless
If the board members don’t put a significant amt of their own money into Titan - vote NO.
Per perry Genova- ENOS SURGICAL PLATFORM IS COMPLETE!
Begs the question is milestone 3 Medtronic CE submission and IDE approval?
Who was the guy that predicted $1.20? If he wasn’t such a Helen he’d step up and deliver on it so we can all continue to add.
Saying Medtronic Hugo can be launched in Q4 this year. Things might speed up more then I previously anticipated
https://www.medtechdive.com/news/robotic-surgery-outlook-boosted-by-hospital-spending-pickup-in-q1/599854/
Totally disagree, the are exponentially more valuable bc of the difficulty to bring a surgical robotic platform to market. Medtronic didn’t go knocking on ALF-x’s door for IP AND KNOW HOW. Here’s a clue on the know how, it means Titan “knows how” to develop surgical robotic platform WITH IP PROTECTION
I had to watch this again. So funny how he picks the one sport that doesn’t allow high school players to go directly to pros. Also, he didn’t mention intellectual property whatsoever (complete lack of understanding of market or its history). Reason ISRG was so dominate and the market leader was their IP and the protection it provided. ANYONE THAT WANTS TO COMPETE FOR NEXT DECADE WILL NEED INTELLECTUAL PROPERTY!
I like my bet on Titan and their global and world leading IP.
As for ALF-X, well I dont give 2 squats it’s fda approved, heck it’s had regulatory clearance for 10 years starting w CE.
Intuitives dominance will come to an end, to think it won’t is naive, the market is ripe for competition. The best bets are on Medtronic and JNJ and acquisition will be strategic and necessary.
Same guy that predicted that Medtronic and intuitive would merge. Was part of the Verb Surgical mgmt team and their project that failed to deliver on all their PR video promises. Of course it’s hard, but he fails to realize and has fallen trap to, it’s easy to talk a good game and miss out on the ones doing the work that do succeed. He is the same guy that said the “hardware didn’t matter, it’s all in the software and AI and data analytics”. Well that software is a dime a dozen but not too many companies have the hardware perfected but TITAN is real close.
This video has zero influence on how I invest my money.
It is amazing how weak the shorts are right now, one would think they should be having a field day w this. If they were in control, we’d be trading around $1.20 but they are just a bunch of helens right now. Bet they throw out claytrader soon.
Just waiting on Medtronic to announce some update on their CE and IDE filing, once you see that on the wire, Titan will announce milestone 3 completion shortly thereafter.
Which also means that the lawsuit against vicarious is bc the executives are very shady and being sued bc of it. If it was overvalued then why would anyone sue? “Hey we are getting a valuation that is way over what we are worth is that good or bad? It’s bad, let’s sue!”
Shady, shady mgmt at vicarious, hence the lawsuits.
Wow a big 30 patents pending which means squat bc they haven’t been granted. So after 8 years of development, they’ve gotten 4 patents granted- stellar IP group they have in house. Vicarious is so far behind Titan and their mgmt is being sued for either being shady (which is what u say) or bc they sold them for the cheap and undervalued them (as u say they are over valued- so why file a lawsuit if the mgmt is getting more then it’s worth). All signs point to shady executives
I imagine jjrj knows more then the UNITED STATES PATENT OFFICE and their entire online patent records.
Vicarious is an unsellable product according to you and it’s valued at, what did u say, $1.2 Billion. Oh and only has 4 patents and btw, based on lawsuit against them the mgmt is either shady or they have completely undervalued it.
Titan is light years ahead of vicarious
Have to love ole funnycomb777 popping his head out of blumkin19 and posting on ihub and the pps goes up. He/It/them must be thinking oh, vey..the shorts are toast.
How about vicarious that has a $1.1B valuation and all it has is 4 patents and some software.
Minimum valuation $5B, items that factor into that:
1. Titan has a single port surgical robotic system
2. The worlds largest medical device company in the world, Medtronic, after all their due diligence chose to partner w Titan for IP AND KNOW HOW
3. Titan also has developed the reoccurring revenue stream in end effectors, hand controllers and surgical drapes - all IP PROTECTED
4. Titan living labs is cranking out patents at an astonishing rate and developing next generation surgical robotic components
5. Titan living labs could be a surgical robotic R&D factory for any acquirer. They let Genova and his engineering team develop IP to protect all the surgical robotic platforms
6. Ready made team of engineers ready to keep rolling upon acquisition w knowledge and know how
7. $10s of BILLIONS dollars (possibly $100s of BILLIONS) of additional MC potential to any acquirer
Just a couple of legit reasons this has a minimum valuation of $5B. Ton more
Reasons to add to the list to support valuation but these are my top ones.
Uh-oh!
Vicarious in a precarious predicament
Vicarious has to have nine degrees bc they don’t have snake arm technology or the wrist roll tech that Titan has. Backing by becton dickinson compared to Medtronic is likely AAA baseball vs major league.
Vicarious is basically a software company and focus on software rather then hardware (hence the lack of patents around the surgical robotic platform). They focus more on software and basically nothing on hardware (think Google and Verb which produce nothing on the hardware side).
https://www.crunchbase.com/organization/vicarious-surgical
Medtronic already has the same virtual/ augmented reality in house (and better then vicarious) bc Medtronic will
Also have next generation hardware
https://www.medtronic.com/ca-en/about/news/extended-reality.html
https://www.prnewswire.com/news-releases/vuzix-to-offer-cross-industry-ar-scalability-takeaways-panel-discussion-featuring-medtronic-and-teamviewer-301265877.html
Like I said, vicarious is way, way behind Titan/Medtronic in bringing a next generation surgical robotic platformS to market
Man is vicarious way behind. Most of what they are seeking w this breakthrough label is stud titan has already completed:
https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program
Ongoing discussions w fda to address premarket review stage
Titan has already received designation guidance from FDA for manufacturing and classification
See what type of communication Titan has had w FDA:
https://www.businesswire.com/news/home/20201230005089/en/Titan-Medical-Provides-Regulatory-Update
Appears vicarious filled out some paperwork for breakthrough- they still have a long way to go, haven’t even discussed anything w fda on quality, manufacturing, indications and on and on.
Titan IDE submission in 2021
Vicarious is sometime in 2023-2025 maybe even 2026
Looks like fda gives this breakthrough designations out like candy and more times then not the company doesn’t make it to market, most are very early stage-prototype companies w limited patent portfolio (all fit the Bill for vicarious)
https://www.fiercebiotech.com/biotech/breakthroughs-broke-down
Do a Google search for FDA breakthrough and they are a dime a dozen and very rarely ever make it to market. Appears it’s companies that don’t have much protection for their product and trying to get a bump in pps. Interesting that vicarious announces it at the same time these SPACs are trying to show value.
Titan has Cary Vance on its board and he was more instrumental in getting the Auris deal done then the guy from vicarious. Plus Medtronic had a partnership w Titan Medical
https://www.nsmedicaldevices.com/news/medtronic-titan-medical-surgical/
Last time the tech and software gurus like gates gets involved in surgical robotics or medical device they complete botch it (look how Google completed screwed up Verb)
How about all of these vicarious patents - all 4 of them.
https://patents.justia.com/assignee/vicarious-surgical-inc
Not one of them on single port technology or even robotic surgery.
When it comes to medical device, if one has a choice to be backed by bill gates or Medtronic - most sensible people would want Medtronic backing - since they are the worlds largest medical device company in the world and work w every healthcare system and hospital and asc in the world. Bill gates has his computer on their desk.
Medtronic is backing Titan
And bill gates is backing vicarious
Titan IDE in 2021
Vicarious IDE is 2023
Let’s look at all this RS split talk: I.e 100m shares outstanding pre RS (input any # outstanding u want). 4-1 RS means 25M O/S (input ur # divided by 4)
BUYOUT - $5B (input any # u want)
100M = $50 per share
25M = $200 pps
100,000 shares pre RS - $5M
25,000 post RS - $5M
So RS doesn’t matter, all that matter is BO price, return is the same no matter what the RS is
So u r a blockbuster video fan and think it will make a comeback. Also, You said Auris, an endoluminal platform can handle 100% of the surgeries (that is a complete lack of understanding of what endoluminal is). As to your question about the deal - Titan can absolutely pay that off before 2023. So u r telling the board that if there is a choice for a benign hysterectomy and both can be successfully performed either using a MP or a SP that patients and doctors would want more incisions on the human body - don’t think that is accurate at all.
That’s fine and agree with you but it’s one thing coming from an anonymous poster and it’s only a possible explanation. As I stated, I’d like the CEO and chairman of the board to explain to us why he decided not to seek royalties for our IP (yes ours, the shareholders). I am looking for that info from him after all he was the one that made the decision. The AGM is June 9 so if it is what u have described then that better come before the my votes need to be submitted.
McNally will either have to get this going sooner then later or explain why he didn’t get royalties for the IP on the Medtronic deal.
The lack of securing royalties, IMO (and based off of what is public knowledge) is a major breach of an executive’s responsibility and will need to be explained to garner a yes vote to remain on the board.
Milestone 3 completed - Medtronic submits for regulatory approval - up over 20% from yesterdays close. Shorts will continue to keep covering but $1.50 is off the table - not enough retail shorters to get it down there.
As for run up- couple of scenarios:
Titan working with colubris
Titan execs have taken part in one of the last offerings
Medtronic already received confirmation from regulatory and payment of $10m to Titan being finalized
Titan submits for CE MARK
REGARDLESS milestone has been completed and Medtronic has submitted for regulatory all in part bc of their partnership w Titan.
Disagree but that is ok. Medtronic basically showed the same robot in their 2019 business day and their most recent reveal. If they hadn’t incorporated some of Titans ip in Hugo then what were they working on since 2019. I thinking having similar end effectors for both Hugo and Titan will help Expedite the Titan regulatory path bc that aspect will already be approved. I absolutely believe Hugo will some way incorporate the camera insertion tube (and it’s capabilities including illumination) into Hugo. I think its possible the hand pieces will also be involved. Having identical hand pieces for a surgeon that is interchangeable bt a single port and multi port system would be a huge plus.
So with Medtronic hitting the milestone of submitting their surgical robotic platform (that they partnered on w Titan to help develop) for regulatory review we now will have to wait 30 days for IDE approval. Reminder that if the FDA doesn’t respond w changes in 30 days, IDE application is automatically approved.
So people think Titan has been transparent And has divulged everything to this point. I would say that really shows a lack of understanding of Titan, Medtronic and the robotic space. Also, no one on this board can say exactly what milestone 3&4 objectives are.
I believe based off what murtha is saying about Medtronic robot and reading bt the lines of the Medtronic deal w Titan that Milestone 3 was regulatory submittal of Hugo. ONE FACT no one can dispute is that MEDTRONIC SUBMITTED HUGO FOR REGULATORY ON MARCH 31.
It will be a minimum of 30 days before they hear back from CE and FDA bodies which means that by the end of April Medtronic will have confirmation from regulatory about HUGO hence why McNally said that they will receive payment for milestone 3 in May - Done and dusted